The US Supreme Court Dobbs decision ’s impact on the future plans of 2023 residency graduates at the University of Utah
This study aimed to understand how the Dobbs decision impacted graduating resident physicians in Utah and to understand residents ’ perspectives on abortion access. (Source: Contraception)
Source: Contraception - November 15, 2023 Category: OBGYN Authors: Alexandra Woodcock, Gentry Carter, Jami Baayd, David K. Turok Tags: Brief Research Article Source Type: research

Development and evaluation of measures to assess self-determination in peripartum contraceptive decision-making
We aimed to adapt and validate person-centered measures to evaluate various contributors to self-determination in perinatal contraceptive decision-making. (Source: Contraception)
Source: Contraception - November 15, 2023 Category: OBGYN Authors: Katharine Sznajder, Katrina Thaler, Jamie Perin, Anne E. Burke, Geoffrey C. Williams, Carolyn Sufrin Tags: Original Research Article Source Type: research

The U.S. Supreme Court Dobbs decision ’s impact on the future plans of 2023 residency graduates at the University of Utah
To understand how the Dobbs decision impacted graduating resident physicians in Utah, and to understand residents ’ perspectives on abortion access. (Source: Contraception)
Source: Contraception - November 15, 2023 Category: OBGYN Authors: Alexandra Woodcock, Gentry Carter, Jami Baayd, David K Turok Source Type: research

Time to treat the climate and nature crisis as one indivisible global health emergency
Over 200 health journals call on the United Nations, political leaders, and health professionals to recognize that climate change and biodiversity loss are one indivisible crisis and must be tackled together to preserve health and avoid catastrophe. This overall environmental crisis is now so severe as to be a global health emergency. (Source: Contraception)
Source: Contraception - November 10, 2023 Category: OBGYN Authors: Kamran Abbasi, Parveen Ali, Virginia Barbour, Thomas Benfield, Kirsten Bibbins-Domingo, Stephen Hancocks, Richard Horton, Laurie Laybourn-Langton, Robert Mash, Peush Sahni, Wadeia Mohammad Sharief, Paul Yonga, Chris Zielinski Tags: Editorial Source Type: research

EDITORIAL: Time to treat the climate and nature crisis as one indivisible global health emergency
Over 200 health journals call on the United Nations, political leaders, and health professionals to recognise that climate change and biodiversity loss are one indivisible crisis and must be tackled together to preserve health and avoid catastrophe. This overall environmental crisis is now so severe as to be a global health emergency. (Source: Contraception)
Source: Contraception - November 10, 2023 Category: OBGYN Authors: Kamran Abbasi, Parveen Ali, Virginia Barbour, Thomas Benfield, Kirsten Bibbins-Domingo, Stephen Hancocks, Richard Horton, Laurie Laybourn-Langton, Robert Mash, Peush Sahni, Wadeia Mohammad Sharief, Paul Yonga, Chris Zielinski Source Type: research

Barriers to abortion provision: A qualitative study among medical students and gynecologists in Berlin, Germany
While abortion is a common medical procedure in Germany, the number of abortion-providing facilities declined by 46% between 2003 and 2022. As existing data do not paint a complete picture of the factors influencing this decline, an understanding into the perspectives of health care professionals (HCPs) is necessary. We set out to examine attitudes of HCPs in Berlin, Germany towards different aspects of abortion, to identify barriers that might prevent them from providing abortions. (Source: Contraception)
Source: Contraception - November 5, 2023 Category: OBGYN Authors: Alicia Baier, Anna-Lisa Behnke Source Type: research

Editorial Board
(Source: Contraception)
Source: Contraception - November 3, 2023 Category: OBGYN Source Type: research

Copyright info/Contents
(Source: Contraception)
Source: Contraception - November 3, 2023 Category: OBGYN Source Type: research

Reasons for participation in abortion research in restrictive settings
Following the implementation of a restrictive abortion law in Texas (Senate Bill 8), we conducted in-depth interviews with pregnant people about their experiences seeking abortion care. In this analysis, we explore participants ’ motivations for taking part in a research study. (Source: Contraception)
Source: Contraception - November 3, 2023 Category: OBGYN Authors: Klaira Lerma, Whitney Arey, Anna Chatillon, Kari White Tags: Original Research Article Source Type: research

Helping patients choose between pain control options for outpatient procedural abortion at less than 12 weeks gestation
To identify predictors of patient satisfaction with their chosen pain control regimen for procedural abortion at less than 12 weeks gestation in the outpatient setting. (Source: Contraception)
Source: Contraception - October 31, 2023 Category: OBGYN Authors: Rebecca H. Allen, Jennifer Fortin, Rie Maurer, Deborah Bartz, Alisa B. Goldberg, Alison Edelman, Melissa A. Clark Source Type: research

Using prevention cascades to investigate coverage of contraception services among young women enrolled in a large-scale combination HIV prevention programme in South Africa
We investigated the coverage of contraception services (excluding condoms) to prevent unintended pregnancy among young women and girls aged 15-24 years who were beneficiaries of one of the two largest combination HIV and pregnancy prevention programme in South Africa. (Source: Contraception)
Source: Contraception - October 18, 2023 Category: OBGYN Authors: Kim Jonas, Kate Bergh, Zoe Duby, Kgahliso Mangoale, Neo Mogari, Caroline Kuo, Tarylee Reddy, Catherine Mathews Tags: Original Research Article Source Type: research

Comparison of Estrogenic Components Used for Hormonal Contraception
Attempts have been made over the years to replace ethinyl estradiol (EE) in combined oral contraceptives (COCs) with the less potent natural estrogen estradiol (E2), or its prodrug, E2 valerate (E2V), to improve the safety and tolerability of COCs. Recently, a COC formulation incorporating a novel weak natural estrogen, estetrol (E4), combined with drospirenone, has become available. Here we present a comparative analysis of the three prevailing estrogens used in COCs, focusing on their structure-function relationships, receptor-binding affinity, potency, metabolism, pharmacokinetic parameters, and pharmacodynamics. (Source: Contraception)
Source: Contraception - October 18, 2023 Category: OBGYN Authors: Frank Z. Stanczyk, Sharon A. Winer, Jean-Michel Foidart, David F. Archer Source Type: research

Effects of aromatherapy on patient satisfaction with procedural abortion at less than 10 weeks ’ gestation: a randomized controlled trial
To compare satisfaction with procedural abortion prior to 10 weeks ’ gestation in patients randomized to lavender essential oil aromatherapy versus placebo (jojoba oil). (Source: Contraception)
Source: Contraception - October 17, 2023 Category: OBGYN Authors: Leanne L. Free, Jeanelle Sheeder, Rebecca H. Cohen Tags: Original Research Article Source Type: research

Characteristics and hormonal contraception use patterns of levonorgestrel 13.5  mg intrauterine device users in Sweden 2014–2016
The levonorgestrel-releasing intrauterine device containing 13.5  mg of levonorgestrel (LNG 13.5 mg IUD), Jaydess, was approved for contraception by the European Medicines Agency in 2013. We aimed to describe the characteristics of new users of LNG 13.5 mg IUD in Sweden within the first 3 years after approval (2014–2016). (Source: Contraception)
Source: Contraception - October 14, 2023 Category: OBGYN Authors: Marie Linder, Juliane Schoendorf, Federica Pisa, Renate Schulze-Rath, Carolyn E. Cesta Tags: Original Research Article Source Type: research

Characteristics and hormonal contraception use patterns of levonorgestrel 13.5 mg intrauterine device users in Sweden 2014 –2016
The levonorgestrel-releasing intrauterine device containing 13.5 mg of levonorgestrel (LNG 13.5 mg IUD), Jaydess ®, was approved for contraception by the European Medicines Agency in 2013. We aimed to describe the characteristics of new users of LNG 13.5 mg IUD in Sweden within the first 3 years after approval (2014–2016). (Source: Contraception)
Source: Contraception - October 14, 2023 Category: OBGYN Authors: Marie Linder, Juliane Schoendorf, Federica Pisa, Renate Schulze-Rath, Carolyn E. Cesta Tags: Original Research Article Source Type: research